Literature DB >> 24222381

CD11c⁺ cells primed with unrelated antigens facilitate an accelerated immune response to influenza virus in mice.

Laura E Richert1, Agnieszka Rynda-Apple, Ann L Harmsen, Soo Han, James A Wiley, Trevor Douglas, Kyle Larson, Rachelle V Morton, Allen G Harmsen.   

Abstract

Recent evidence suggests that an individual's unique history and sequence of exposures to pathogens and antigens may dictate downstream immune responses to disparate antigens. We show that the i.n. delivery of nonreplicative virus-like particles (VLPs), which bear structural but no antigenic similarities to respiratory pathogens, acts to prime the lungs of both C56BL/6 and BALB/c mice, facilitating heightened and accelerated primary immune responses to high-dose influenza challenge, thus providing a nonpathogenic model of innate imprinting. These responses correspond closely to those observed following natural infection with the opportunistic fungus, Pneumocystis murina, and are characterized by accelerated antigen processing by DCs and alveolar macrophages, an enhanced influx of cells to the local tracheobronchial lymph node, and early upregulation of T-cell co-stimulatory/adhesion molecules. CD11c⁺ cells, which have been directly exposed to VLPs or Pneumocystis are necessary in facilitating enhanced clearance of influenza virus, and the repopulation of the lung by Ly-6C⁺ precursors relies on CCR2 expression. Thus, immune imprinting 72 h after VLP-priming, or 2 weeks after Pneumocystis-priming is CCR2-mediated and results from the enhanced antigen processing, maturation, and trafficking abilities of DCs and alveolar macrophages, which cause accelerated influenza-specific primary immune responses and result in superior viral clearance.
© 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  CCR2; Dendritic cell; Influenza; Innate imprinting; Pneumocystis murina

Mesh:

Substances:

Year:  2014        PMID: 24222381      PMCID: PMC3926668          DOI: 10.1002/eji.201343587

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  59 in total

1.  The immunological synapse: a molecular machine controlling T cell activation.

Authors:  A Grakoui; S K Bromley; C Sumen; M M Davis; A S Shaw; P M Allen; M L Dustin
Journal:  Science       Date:  1999-07-09       Impact factor: 47.728

Review 2.  Dendritic-cell trafficking to lymph nodes through lymphatic vessels.

Authors:  Gwendalyn J Randolph; Veronique Angeli; Melody A Swartz
Journal:  Nat Rev Immunol       Date:  2005-08       Impact factor: 53.106

3.  Crystal structure of a small heat-shock protein.

Authors:  K K Kim; R Kim; S H Kim
Journal:  Nature       Date:  1998-08-06       Impact factor: 49.962

4.  Development of bronchus associated lymphoid tissue (BALT) in human lung disease: a normal host defence mechanism awaiting therapeutic exploitation?

Authors:  P G Holt
Journal:  Thorax       Date:  1993-11       Impact factor: 9.139

Review 5.  Induction, exacerbation and inhibition of allergic and autoimmune diseases by infection.

Authors:  Thomas Kamradt; Rolf Göggel; Klaus J Erb
Journal:  Trends Immunol       Date:  2005-05       Impact factor: 16.687

Review 6.  ICAM-1 co-stimulates target cells to facilitate antigen presentation.

Authors:  Tatiana Lebedeva; Michael L Dustin; Yuri Sykulev
Journal:  Curr Opin Immunol       Date:  2005-06       Impact factor: 7.486

7.  A major lung CD103 (alphaE)-beta7 integrin-positive epithelial dendritic cell population expressing Langerin and tight junction proteins.

Authors:  Sun-Sang J Sung; Shu Man Fu; C Edward Rose; Felicia Gaskin; Shyr-Te Ju; Steven R Beaty
Journal:  J Immunol       Date:  2006-02-15       Impact factor: 5.422

8.  Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2.

Authors:  Natalya V Serbina; Eric G Pamer
Journal:  Nat Immunol       Date:  2006-02-05       Impact factor: 25.606

9.  Interleukin-7 facilitates HIV-1 transmission to cervico-vaginal tissue ex vivo.

Authors:  Andrea Introini; Christophe Vanpouille; Andrea Lisco; Jean-Charles Grivel; Leonid Margolis
Journal:  PLoS Pathog       Date:  2013-02-07       Impact factor: 6.823

10.  THE IMMUNOLOGICAL BASIS OF ACQUIRED CELLULAR RESISTANCE.

Authors:  G B MACKANESS
Journal:  J Exp Med       Date:  1964-07-01       Impact factor: 14.307

View more
  10 in total

1.  Nasal priming with immunobiotic Lactobacillus rhamnosus modulates inflammation-coagulation interactions and reduces influenza virus-associated pulmonary damage.

Authors:  Hortensia Zelaya; Asuka Tada; Maria Guadalupe Vizoso-Pinto; Susana Salva; Paulraj Kanmani; Graciela Agüero; Susana Alvarez; Haruki Kitazawa; Julio Villena
Journal:  Inflamm Res       Date:  2015-06-14       Impact factor: 4.575

Review 2.  Virus-like particles as antigenic nanomaterials for inducing protective immune responses in the lung.

Authors:  Agnieszka Rynda-Apple; Dustin P Patterson; Trevor Douglas
Journal:  Nanomedicine (Lond)       Date:  2014       Impact factor: 5.307

Review 3.  Mechanisms of cellular and humoral immunity through the lens of VLP-based vaccines.

Authors:  Hunter McFall-Boegeman; Xuefei Huang
Journal:  Expert Rev Vaccines       Date:  2022-01-24       Impact factor: 5.217

Review 4.  Virus-Based Nanoparticles as Versatile Nanomachines.

Authors:  Kristopher J Koudelka; Andrzej S Pitek; Marianne Manchester; Nicole F Steinmetz
Journal:  Annu Rev Virol       Date:  2015-09-25       Impact factor: 10.431

5.  Antigen-loaded dendritic cell migration: MR imaging in a pancreatic carcinoma model.

Authors:  Zhuoli Zhang; Weiguo Li; Daniele Procissi; Kangan Li; Alexander Y Sheu; Andrew C Gordon; Yang Guo; Khashayarsha Khazaie; Yi Huan; Guohong Han; Andrew C Larson
Journal:  Radiology       Date:  2014-09-15       Impact factor: 11.105

Review 6.  Passive broad-spectrum influenza immunoprophylaxis.

Authors:  Cassandra M Berry; William J Penhale; Mark Y Sangster
Journal:  Influenza Res Treat       Date:  2014-09-22

7.  Increased CD40 Expression Enhances Early STING-Mediated Type I Interferon Response and Host Survival in a Rodent Malaria Model.

Authors:  Xiangyu Yao; Jian Wu; Meng Lin; Wenxiang Sun; Xiao He; Channe Gowda; Silvia Bolland; Carole A Long; Rongfu Wang; Xin-Zhuan Su
Journal:  PLoS Pathog       Date:  2016-10-07       Impact factor: 6.823

8.  In situ vaccination with cowpea mosaic virus nanoparticles suppresses metastatic cancer.

Authors:  P H Lizotte; A M Wen; M R Sheen; J Fields; P Rojanasopondist; N F Steinmetz; S Fiering
Journal:  Nat Nanotechnol       Date:  2015-12-21       Impact factor: 39.213

9.  High expression of CD38 and MHC class II on CD8+ T cells during severe influenza disease reflects bystander activation and trogocytosis.

Authors:  Xiaoxiao Jia; Brendon Y Chua; Liyen Loh; Marios Koutsakos; Lukasz Kedzierski; Moshe Olshansky; William R Heath; So Young Chang; Jianqing Xu; Zhongfang Wang; Katherine Kedzierska
Journal:  Clin Transl Immunology       Date:  2021-09-08

Review 10.  Pathogenesis of Respiratory Viral and Fungal Coinfections.

Authors:  Fabián Salazar; Elaine Bignell; Gordon D Brown; Peter C Cook; Adilia Warris
Journal:  Clin Microbiol Rev       Date:  2021-11-17       Impact factor: 26.132

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.